Page last updated: 2024-08-23

desogestrel and Corpus Luteum Cyst

desogestrel has been researched along with Corpus Luteum Cyst in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (14.29)	18.7374
1990's	3 (42.86)	18.2507
2000's	2 (28.57)	29.6817
2010's	1 (14.29)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alhajri, M; Greenblatt, E; Liu, KE	1
Ayoğlu, F; Barut, A; Bayar, U	1
Abbamonte, LH; Ferrero, S; Fulcheri, E; Ragni, N; Remorgida, V	1
Egarter, C; Huber, J; Putz, M; Speiser, P; Strohmer, H; Wenzl, R	1
Bielfeld, P; Conrad, M; Graf, M; Krüssel, JS; Rudolf, K	1
Biljan, MM; Bissonnette, F; Dean, N; Hemmings, R; Mahutte, NG; Tan, SL	1
Jackson, R; Newton, JR	1

Trials

6 trial(s) available for desogestrel and Corpus Luteum Cyst

Article	Year
A randomized controlled trial of NuvaRing versus combined oral contraceptive pills for pretreatment in in vitro fertilization cycles. Fertility and sterility, 2011, Volume: 96, Issue:3 Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Fertilization in Vitro; Humans; Infertility, Female; Ovarian Cysts; Ovary; Patient Satisfaction; Pregnancy; Pregnancy Rate; Young Adult	2011
Diagnosis and management of simple ovarian cysts. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2005, Volume: 91, Issue:2 Topics: Adult; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Laparoscopy; Middle Aged; Ovarian Cysts; Treatment Outcome; Ultrasonography	2005
Letrozole and desogestrel-only contraceptive pill for the treatment of stage IV endometriosis. The Australian & New Zealand journal of obstetrics & gynaecology, 2007, Volume: 47, Issue:3 Topics: Adult; Aromatase Inhibitors; Contraceptives, Oral, Synthetic; Desogestrel; Drug Therapy, Combination; Endometriosis; Female; Humans; Letrozole; Nitriles; Ovarian Cysts; Pelvic Pain; Prospective Studies; Triazoles	2007
Ovarian function during low-dose oral contraceptive use. Contraception, 1995, Volume: 51, Issue:6 Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Dose-Response Relationship, Drug; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Norgestrel; Ovarian Cysts; Ovary; Patient Compliance; Progesterone; Prospective Studies; Smoking; Ultrasonography	1995
[Regression of functional cysts: high dosage ovulation inhibitor and gestagen therapy has no added effect]. Geburtshilfe und Frauenheilkunde, 1995, Volume: 55, Issue:7 Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Dose-Response Relationship, Drug; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lynestrenol; Ovarian Cysts; Ovary; Progesterone Congeners; Prospective Studies; Remission, Spontaneous; Retrospective Studies; Treatment Outcome	1995
Pharmacodynamics of a contraceptive vaginal ring releasing 3-keto-desogestrel. Contraception, 1989, Volume: 39, Issue:6 Topics: Administration, Intravaginal; Adult; Desogestrel; Estradiol; Female; Humans; Norpregnenes; Ovarian Cysts; Ovary; Progesterone; Progesterone Congeners	1989

Other Studies

1 other study(ies) available for desogestrel and Corpus Luteum Cyst

Article	Year
Pretreatment with an oral contraceptive is effective in reducing the incidence of functional ovarian cyst formation during pituitary suppression by gonadotropin-releasing hormone analogues. Journal of assisted reproduction and genetics, 1998, Volume: 15, Issue:10 Topics: Adult; Buserelin; Case-Control Studies; Desogestrel; Estradiol Congeners; Ethinyl Estradiol; Female; Fertility Agents, Female; Fertilization in Vitro; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Menotropins; Ovarian Cysts; Ovarian Follicle; Ovulation Induction; Pituitary Gland, Anterior; Pregnancy; Pregnancy Rate; Premedication; Progesterone Congeners; Retrospective Studies; Secretory Rate	1998

Article

Year

Pretreatment with an oral contraceptive is effective in reducing the incidence of functional ovarian cyst formation during pituitary suppression by gonadotropin-releasing hormone analogues.

Journal of assisted reproduction and genetics, 1998, Volume: 15, Issue:10

Topics: Adult; Buserelin; Case-Control Studies; Desogestrel; Estradiol Congeners; Ethinyl Estradiol; Female; Fertility Agents, Female; Fertilization in Vitro; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Menotropins; Ovarian Cysts; Ovarian Follicle; Ovulation Induction; Pituitary Gland, Anterior; Pregnancy; Pregnancy Rate; Premedication; Progesterone Congeners; Retrospective Studies; Secretory Rate

1998